Published in J Clin Microbiol on December 01, 1985
Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol (2006) 3.22
Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrob Agents Chemother (1987) 3.06
Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2001) 2.34
Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol (1999) 2.26
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol (1993) 2.25
Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol (2002) 2.21
Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol (2002) 2.12
High-throughput screen for detecting antimycobacterial agents. Antimicrob Agents Chemother (1995) 1.46
Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol (2001) 1.31
Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 1.30
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. Antimicrob Agents Chemother (1993) 1.24
Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008. J Clin Microbiol (2012) 1.22
Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol (1995) 1.17
Development of a rapid method for determining the susceptibility of Mycobacterium tuberculosis to isoniazid using the Gen-Probe DNA Hybridization System. Antimicrob Agents Chemother (1989) 1.13
Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study. J Clin Microbiol (2011) 1.12
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol (1998) 1.09
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis (2008) 1.07
In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1996) 0.97
Rapid method for testing susceptibility of Mycobacterium tuberculosis by using DNA probes. J Clin Microbiol (1997) 0.94
New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay. J Clin Microbiol (1996) 0.92
Species spectrum of nontuberculous mycobacteria isolated from clinical specimens in Kuwait. Curr Microbiol (2008) 0.92
Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1986) 0.91
Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry. J Clin Microbiol (1999) 0.90
French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex. Antimicrob Agents Chemother (1995) 0.88
Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J Clin Microbiol (1996) 0.83
Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Ann Clin Microbiol Antimicrob (2009) 0.82
In vitro activity of roxithromycin against the Mycobacterium tuberculosis complex. Antimicrob Agents Chemother (1995) 0.79
Modulation of Host Autophagy during Bacterial Infection: Sabotaging Host Munitions for Pathogen Nutrition. Front Immunol (2016) 0.79
Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs. Braz J Microbiol (2013) 0.77
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action. Antimicrob Agents Chemother (2016) 0.75
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ (1969) 12.55
Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis (1977) 11.20
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol (1983) 10.49
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. Bull World Health Organ (1963) 9.26
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77
Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol (1983) 2.08
Influence of the medium on the in vitro susceptibility of Mycobacterium tuberculosis to ethambutol. Am Rev Respir Dis (1970) 1.80
Studies on Some Biological Aspects of Dihydrostreptomycin. J Bacteriol (1947) 1.15
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (1998) 10.78
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol (1983) 10.49
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Role of solid media when used in conjunction with the BACTEC system for mycobacterial isolation and identification. J Clin Microbiol (1991) 3.60
Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis (1984) 3.25
Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone. J Clin Microbiol (1984) 2.39
Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol (1999) 2.26
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol (1993) 2.25
Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem (1997) 2.14
Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol (1983) 2.08
Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay. J Clin Microbiol (1995) 1.85
Test for differentiation of M. tuberculosis and M. bovis from other mycobacteria. Can J Microbiol (1978) 1.77
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol (1999) 1.73
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis (1994) 1.71
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Sensory and neural degeneration with aging, as seen in microdissections of the human inner ear. Ann Otol Rhinol Laryngol (1972) 1.59
Scotochromogenic mycobacteria which appear intermediate between Mycobacterium avium-intracellulare and Mycobacterium scrofulaceum. Am Rev Respir Dis (1977) 1.59
Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1990) 1.56
Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res (2000) 1.48
Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia. J Clin Microbiol (1988) 1.40
Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther (1993) 1.38
Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis (1981) 1.32
Direct antimicrobial drug susceptibility testing of Mycobacterium tuberculosis by the radiometric method. Diagn Microbiol Infect Dis (1988) 1.30
The role of vasoconstriction in noise-induced hearing loss. Ann Otol Rhinol Laryngol (1971) 1.29
Phosphorylation of HSP27 during development and decay of thermotolerance in Chinese hamster cells. J Cell Physiol (1991) 1.26
Radiometric selective inhibition tests for differentiation of Mycobacterium tuberculosis, Mycobacterium bovis, and other mycobacteria. J Clin Microbiol (1985) 1.24
Use of urease test disks in the identification of mycobacteria. J Clin Microbiol (1975) 1.20
Heat-resistant variants of Chinese hamster fibroblasts altered in expression of heat shock protein. Proc Natl Acad Sci U S A (1985) 1.20
Comparative otopathology: aging, noise, and ototoxic drugs. Adv Otorhinolaryngol (1973) 1.20
Analysis of genetic polymorphism in the phospholipase region of Mycobacterium tuberculosis. J Clin Microbiol (1997) 1.19
Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test. J Clin Microbiol (1996) 1.19
Serological specificity of Mycobacterium tuberculosis glycolipids. Acta Leprol (1989) 1.16
Comparative tests of gentamicin ototoxicity. J Infect Dis (1969) 1.15
Vascular changes in the human inner ear associated with aging. Ann Otol Rhinol Laryngol (1972) 1.11
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Aminoglycoside-induced cochlear pathology in man. Acta Otolaryngol Suppl (1981) 1.07
Amino acid analogs while inducing heat shock proteins sensitize CHO cells to thermal damage. J Cell Physiol (1985) 1.07
Laboratory services for mycobacterial diseases. Am Rev Respir Dis (1975) 1.06
Hearing thresholds with outer and inner hair cell loss. Am J Otolaryngol (1979) 1.05
Glycolipids of recent clinical isolates of Mycobacterium tuberculosis: chemical characterization and immunoreactivity. J Gen Microbiol (1989) 1.04
A stress-inducible 40 kDa protein (hsp40): purification by modified two-dimensional gel electrophoresis and co-localization with hsc70(p73) in heat-shocked HeLa cells. J Cell Sci (1993) 1.04
Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients. Diagn Microbiol Infect Dis (1993) 1.04
Tumor promoters alter gene expression and protein phosphorylation in avian cells in culture. Proc Natl Acad Sci U S A (1981) 1.03
Occupational transmission of Mycobacterium tuberculosis to health care workers in a university hospital in Lima, Peru. Clin Infect Dis (2001) 1.02
Strial atrophy in clinical and experimental deafness. Laryngoscope (1972) 1.02
A direct approach to cochlear anatomy and pathology in man. Arch Otolaryngol (1967) 1.01
Alcohol consumption and the risk of major upper gastrointestinal bleeding. Am J Gastroenterol (1995) 0.99
Nature of thrombin-induced sustained increase in cytosolic calcium concentration in cultured endothelial cells. J Biol Chem (1989) 0.98
Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis. J Clin Pathol (1981) 0.98
Periphery to centre quality control of sputum smear microscopy and 'rapid fading' of Ziehl-Neelsen staining. Int J Tuberc Lung Dis (2000) 0.98
Microcirculation in the labyrinth. Arch Otorhinolaryngol (1976) 0.97
Degeneration patterns in human ears exposed to noise. Ann Otol Rhinol Laryngol (1977) 0.95
Cochlear microvasculature in normal and damaged ears. Laryngoscope (1972) 0.94
Evaluation of a simple method for growing Mycobacterium haemophilum. J Clin Microbiol (1985) 0.94
Hearing loss and cochlear pathology in monkeys after noise exposure. Acta Otolaryngol (1976) 0.93
Otolithic membranes of the saccule and utricle in man. Science (1967) 0.92
Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan. Tubercle (1989) 0.92
The patas monkey as a model for dihydrostreptomycin ototoxicity. Acta Otolaryngol (1977) 0.92
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91
Genito-urinary tuberculosis in Pakistan. J Pak Med Assoc (1981) 0.91
Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1986) 0.91
Antimycobacterial properties of glycyl hydroxyamic acid and beta-alanyl hydroxamic acid. Am Rev Respir Dis (1965) 0.89
Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. Int J Tuberc Lung Dis (1998) 0.89
Auditory intensity discrimination after selective loss of cochlear outer hair cells. Science (1981) 0.88
Effects of hypothermia, potassium , and verapamil on the action potential characteristics of canine cardiac Purkinje fibers. Anesthesiology (1995) 0.88
Hearing loss and cochlear pathology in the monkey (Macaca) following exposure to high levels of noise. Arch Otorhinolaryngol (1978) 0.87
Evaluation of a new blood culture medium for mycobacteria. Am J Clin Pathol (1989) 0.87
Development of an enzyme-linked immunosorbent assay (ELISA) combined with a streptavidin-biotin and enzyme amplification method to detect anti-2,3-di-o-acyltrehalose (DAT) antibodies in patients with tuberculosis. J Immunol Methods (1994) 0.87
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.86
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2011) 0.86
Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig. Otolaryngol Head Neck Surg (1984) 0.86
Some physiological factors in noise-induced hearing loss. Am Ind Hyg Assoc J (1968) 0.86
Pathology of neuroepithelial suprastructures of the human inner ear. Am J Otolaryngol (1982) 0.85
Ototoxic hearing loss and cochlear pathology in the monkey. Ann Otol Rhinol Laryngol (1969) 0.85
Functional and morphological changes in experimental endolymphatic hydrops. Acta Otolaryngol (1984) 0.85
Light microscopic observations of the inner ear in man and monkey. Ann Otol Rhinol Laryngol (1968) 0.85
Pulmonary alveolar proteinosis. Origin of proteins in pulmonary washings. Am J Clin Pathol (1967) 0.85
The relationship between hsp 70 localization and heat resistance. Exp Cell Res (1992) 0.84
Serodiagnostic tests for tuberculosis: a need for assessment of their operational predictive accuracy and acceptability. Bull World Health Organ (1990) 0.84
TPA induces simultaneous alterations in the synthesis and organization of vimentin. Exp Cell Res (1983) 0.84
Dot blot assay for detection of antidiacyltrehalose antibodies in tuberculous patients. Clin Diagn Lab Immunol (1999) 0.84
Major upper gastrointestinal bleeding and the use of calcium channel blockers. Lancet (1999) 0.83
Hsp70 translocates into a cytoplasmic aggregate during lymphocyte activation. J Cell Physiol (1995) 0.82
More on periphery to centre quality control of sputum smear microscopy and 'rapid fading' of Ziehi-Neelsen staining. Int J Tuberc Lung Dis (2001) 0.82
"Neural" responses to acoustic stimulation after destruction of cochlear hair cells. Arch Otorhinolaryngol (1979) 0.81
Apical hair cells and hearing. Hear Res (1990) 0.81
Cytoarchitectural basis of the cochlear transducer. Cold Spring Harb Symp Quant Biol (1965) 0.81
Threshold elevation at high frequencies of the auditory nerve action potentials in acute versus chronic recordings in guinea pigs. Hear Res (1980) 0.81
Origin and significance of mycobacterium xenopi in clinical specimens. I. Water as a source of contamination. Bull Int Union Tuberc (1976) 0.81
Cochlear and vestibular lesions in capsular otosclerosis as seen in microdissection. Ann Otol Rhinol Laryngol Suppl (1978) 0.81
Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes. Biol Chem Hoppe Seyler (1988) 0.81
Abnormal otoconia and calcification in the labyrinths of deaf Dalmatian dogs. Acta Otolaryngol (1984) 0.80
The ubiquitin-mediated proteolytic system: involvement of molecular chaperones, degradation of oncoproteins, and activation of transcriptional regulators. Cold Spring Harb Symp Quant Biol (1995) 0.80
Hereditary deafness with hydrops and anomalous calcium phosphate deposits. Am J Otolaryngol (1981) 0.80
Structure of the reticular lamina and repair after noise injury. Rev Laryngol Otol Rhinol (Bord) (1993) 0.80
Specificity of Mycobacterium tuberculosis phenolic glycolipid (PGL-Tb1) antiserum. Ann Inst Pasteur Microbiol (1989) 0.80
Melanocytes of the vestibular labyrinth and their relationship to the microvasculature. Ann Otol Rhinol Laryngol (1974) 0.80
Amplification and altered expression of the hsc70/U14 snoRNA gene in a heat resistant Chinese hamster cell line. Cell Stress Chaperones (1996) 0.80